Publikationen in Zusammenarbeit mit Forschern von Institut Pasteur (13)

2022

  1. Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis

    Nature Communications, Vol. 13, Núm. 1

  2. Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2

    Journal of Experimental Medicine, Vol. 219, Núm. 7

2021

  1. Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies

    Cell Reports Medicine, Vol. 2, Núm. 5

  2. Functional heterogeneity of mammalian IFITM proteins against HIV-1

    Journal of Virology, Vol. 95, Núm. 18

  3. Revisiting an IgG Fc Loss-of-Function Experiment: The Role of Complement in HIV Broadly Neutralizing Antibody b12 Activity

    mBio, Vol. 12, Núm. 5

  4. SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation

    EMBO Journal, Vol. 40, Núm. 24

2020

  1. A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

    Science Translational Medicine, Vol. 12, Núm. 559

  2. Anti-HIV-1 antibodies trigger non-lytic complement deposition on infected cells

    EMBO Reports, Vol. 21, Núm. 2

  3. Flow cytometry analysis of HIV-1 env conformations at the surface of infected cells and virions: Role of Nef, CD4, and SERINC5

    Journal of Virology, Vol. 94, Núm. 6

  4. Syncytia formation by SARS-CoV-2-infected cells

    EMBO Journal, Vol. 39, Núm. 23

2019

  1. Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01

    Cell Host and Microbe, Vol. 26, Núm. 5, pp. 623-637.e8

2018

  1. Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity

    Cell Reports, Vol. 23, Núm. 9, pp. 2568-2581

  2. HIV-1 cell-to-cell transmission and broadly neutralizing antibodies

    Retrovirology, Vol. 15, Núm. 1